• AstraZeneca Launches FluMist Home For Easy At Home Flu Vaccination

    Source: NASDAQ US Markets / 15 Aug 2025 05:31:24   America/Los_Angeles

    (RTTNews) - AstraZeneca announced the launch of FluMist Home, an at-home delivery service for FLUMIST (Influenza Vaccine Live, Intranasal). This marks a major milestone in public health, as FLUMIST becomes the first and only FDA-approved seasonal influenza vaccine that can be sel https://www.nasdaq.com/articles/astrazeneca-launches-flumist-home-easy-home-flu-vaccination
Share on,